Create a narrative

Becton Dickinson Community

NYSE:BDX Community

1 Narratives written by author
0 Comments on narratives written by author
33 Fair Values set on narratives written by author

Becton Dickinson

AN

AnalystConsensusTarget

AnalystConsensusTarget

Based on Analyst Price Targets

Advanced Diagnostics And Tissue Regeneration Will Expand Decentralized Healthcare

Key Takeaways Innovative product launches and biologics delivery advancements position BD to benefit from rising chronic disease trends and drive sustained revenue growth. Business transformation, operational efficiency gains, and emerging market expansion are set to enhance margins, cash flow stability, and global market diversification.

US$208

FV

10.3% undervalued

4.87%

Revenue growth p.a.

0

0

17

13 days ago